370 related articles for article (PubMed ID: 14687828)
1. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A
Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients.
Elsammak M; Refai W; Elsawaf A; Abdel-Fattah I; Abd Elatti E; Ghazal A
Curr Med Res Opin; 2005 Apr; 21(4):527-34. PubMed ID: 15899101
[TBL] [Abstract][Full Text] [Related]
3. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
4. TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad.
Knobler H; Schattner A
QJM; 2005 Jan; 98(1):1-6. PubMed ID: 15625348
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
[TBL] [Abstract][Full Text] [Related]
6. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection.
Poussier A; Lebouvier M; Penfornis A; Di Martino V; Buffier P; Verges B; Hillon P; Petit JM
Diabet Med; 2008 Oct; 25(10):1237-40. PubMed ID: 19046205
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokines in insulin-treated patients with type 2 diabetes.
Mavridis G; Souliou E; Diza E; Symeonidis G; Pastore F; Vassiliou AM; Karamitsos D
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):471-6. PubMed ID: 17976964
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans.
Fischer CP; Perstrup LB; Berntsen A; Eskildsen P; Pedersen BK
Clin Immunol; 2005 Nov; 117(2):152-60. PubMed ID: 16112617
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia.
Antonelli A; Ferri C; Ferrari SM; Ghiri E; Goglia F; Pampana A; Bruschi F; Fallahi P
Arthritis Rheum; 2009 Dec; 60(12):3841-7. PubMed ID: 19950277
[TBL] [Abstract][Full Text] [Related]
10. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus.
Fernandez-Real JM; Lainez B; Vendrell J; Rigla M; Castro A; Peñarroja G; Broch M; Pérez A; Richart C; Engel P; Ricart W
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E952-9. PubMed ID: 11882518
[TBL] [Abstract][Full Text] [Related]
11. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
12. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
[TBL] [Abstract][Full Text] [Related]
14. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
16. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection.
Itoh Y; Okanoue T; Ohnishi N; Sakamoto M; Nishioji K; Nakagawa Y; Minami M; Murakami Y; Kashima K
Am J Gastroenterol; 1999 May; 94(5):1332-40. PubMed ID: 10235215
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.
Antoniades C; Tousoulis D; Tountas C; Tentolouris C; Toutouza M; Vasiliadou C; Tsioufis C; Toutouzas P; Stefanadis C
Diabet Med; 2004 Jun; 21(6):552-8. PubMed ID: 15154938
[TBL] [Abstract][Full Text] [Related]
19. Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C.
Hung CH; Lee CM; Chen CH; Hu TH; Jiang SR; Wang JH; Lu SN; Wang PW
Liver Int; 2009 Aug; 29(7):1086-93. PubMed ID: 19302182
[TBL] [Abstract][Full Text] [Related]
20. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
